#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
James Bianco Email
CEO . Morphogenesis
Tampa, FL
LocationPrimary Email
How to contact James Bianco
Join and see James's contact info for free!Current Roles
Employees:
0Revenue:
$4.3MAbout
Morphogenesis is an emerging cell therapy company developing therapeutic products and devices for the fast-growing, multi-billion dollar cell therapy, tissue engineering and immunotherapy markets. The Company's initiatives can be broken down into three platforms or divisions; Cell Therapy, Immune Therapy and Supporting Technologies. The Problem The continued increase of chronic disease has made it clear that the future of medicine depends on our ability to develop ways to repair, replace or destroy the cells that make up tissue and organ systems which have become defective. The Morphogenesis Solution The Company believes that cells, themselves, represent a more effective mode of treatment than drugs and is developing products which will allow their widespread use as therapeutics. A critical component in any type of cell therapy is the interaction of the therapeutic cell and the immune system of the patient receiving the treatment. Morphogenesis has approached this key issue from both perspectives, i.e., by seeking to evade immune attack where necessary and to harness the immune response when advantageous. For example, replacement cells may come from one's own body, a donor or an animal, but unless the cells come from the patient himself, their use is limited because the transplanted cells will be rejected by the patient's immune system. Morphogenesis' Cell Therapy Division has developed a revolutionary technology which is slated to solve the problem of graft rejection and in turn, address the tissue shortage crisis as well. Alternatively, the Company's Immune Therapy Division is developing ways to use cells in the fight against cancer. Morphogenesis' therapeutic cancer vaccine has already proven efficacyin pre-clinical studies in its ability to focus and target the immune response against cancer cells. The Company's Supporting Technologies Division is actively pursuing ways to identify, isolate and purify stem cells. The vanguard product is a clinical device designed to purify hematopoietic stem cells from peripheral blood. This Division has also developed proprietary methods, cell lines and monoclonal antibodies for the identification of hematopoietic stem cells.Morphogenesis Address
10500 University Center DriveTampa, FL
United States